재택 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The At-Home Lab Testing Market size is expected to reach USD 12.79 Billion in 2034 from USD 9.50 Billion (2025) growing at a CAGR of 3.36% during 2026-2034.

The Global At-Home Lab Testing Market is expanding rapidly due to increasing consumer preference for convenient and private healthcare solutions. Advances in diagnostic technology have enabled individuals to conduct tests for conditions such as diabetes, cholesterol, infections, and hormonal imbalances from home. Growing awareness of preventive healthcare and digital health platforms is significantly driving market growth.

Key growth drivers include telehealth expansion, user-friendly sample collection kits, and faster result processing through online platforms. Consumers appreciate the convenience of home testing without visiting clinics or laboratories. Rising healthcare costs and increased focus on personal wellness are further supporting demand. Regulatory approvals and improved test accuracy are also strengthening consumer confidence.

Looking forward, the market is expected to benefit from integration with mobile health apps and AI-based health tracking systems. Continuous innovation in rapid testing technologies will expand the range of detectable conditions. Emerging markets with improving internet connectivity and healthcare access offer substantial growth potential. As personalized healthcare becomes more prominent, at-home lab testing is projected to witness sustained global expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

• Glucose Test Kits
• Infectious Diseases Test Kits
• Pregnancy Test Kits
• Cholesterol Test Strips
• Drugs of Abuse Test Kits
• Coagulation Monitoring Tests
• Other Test Types

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies/Drug Stores
• Online Pharmacies

COMPANIES PROFILED

• Quest Diagnostics, LabCorp, Everlywell, LetsGetChecked, Pixel by LabCorp, MyHeritage, 23andMe, BioIQ, Teladoc Health, HealthLinkNow
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AT-HOME LAB TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Test Type
• 4.2. Glucose Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Infectious Diseases Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Pregnancy Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Cholesterol Test Strips Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Drugs of Abuse Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Coagulation Monitoring Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Other Test Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AT-HOME LAB TESTING MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Distribution Channel
• 5.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Retail Pharmacies/Drug Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AT-HOME LAB TESTING MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Test Type
  • 6.2.2 By Distribution Channel
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Test Type
  • 6.3.2 By Distribution Channel
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Test Type
  • 6.4.2 By Distribution Channel
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Test Type
  • 6.5.2 By Distribution Channel
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Test Type
  • 6.6.2 By Distribution Channel
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL AT-HOME LAB TESTING INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Quest Diagnostics
  • 8.2.2 LabCorp
  • 8.2.3 Everlywell
  • 8.2.4 LetsGetChecked
  • 8.2.5 Pixel By LabCorp
  • 8.2.6 MyHeritage
  • 8.2.7 23andMe
  • 8.2.8 BioIQ
  • 8.2.9 Teladoc Health
  • 8.2.10 HealthLinkNow